NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8214
-0.0386 (-4.49%)
At close: May 29, 2026, 4:00 PM EDT
0.8214
0.00 (0.00%)
After-hours: May 29, 2026, 4:00 PM EDT
NeuroSense Therapeutics Employees
NeuroSense Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$654,412
Market Cap
29.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -1 | -5.56% |
| Dec 31, 2023 | 18 | 4 | 28.57% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Evaxion | 46 |
| Senti Biosciences Holdings | 39 |
| Boundless Bio | 28 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| Tevogen Bio Holdings | 18 |
| Tvardi Therapeutics | 12 |
NRSN News
- 1 day ago - The Trump Administration Is in Talks to Fund U.S. Drone Companies - WSJ
- 25 days ago - NeuroSense Therapeutics Slides: Corporate presentation - Filings
- 4 weeks ago - NeuroSense Announces Pricing of Insider-Led PIPE Financing - PRNewsWire
- 4 weeks ago - NeuroSense announces departure of Chief Medical Officer - TheFly
- 6 weeks ago - NeuroSense Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - NeuroSense granted Brazilian patent covering PrimeC composition - TheFly
- 7 weeks ago - NeuroSense Granted Brazilian Patent Covering PrimeC Composition - PRNewsWire
- 2 months ago - NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements - PRNewsWire